Involvement of 5-HT2A/2B/2C receptors on memory formation: Simple agonism, antagonism, or inverse agonism?

Cellular and Molecular Neurobiology

Volumn 22, Issue 5-6, 2002, Pages 675-688

  Meneses, Alfredo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT2A; 5 HT2B 2C; Autoshaping; Learning consolidation; Rats; Receptors; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 NAPHTHYLPIPERAZINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; KETANSERIN; MESULERGINE; N (2 HYDROXYCYCLOPENTYL) 1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXAMIDE; PIPERAZINE DERIVATIVE; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; LEARNING; MEMORY CONSOLIDATION; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; TASK PERFORMANCE;

ANIMALS; BRAIN; LEARNING; MEMORY; MEMORY DISORDERS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 0036978223     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021800822997     Document Type: Article

References (56)

1. Aghajanian, G. K., and Marek, G. J. (2000). Serotonin model of schizophrenia: Emerging role of glutamate mechanisms. Brain. Res. Rev. 31:302-312.
2. Altman, H. J., and Normile, H. J. (1988). What is the nature of the role of the serotonergic nervous system in learning and memory? Prospects for development of an effective strategy for senile dementia. Neurobiol. Aging 9:627-638.
3. Azmitia, E. C., and Whitaker-Azmitia, P. (1997). Development and adult plasticity of serotonergic neurons and their target cells. In Baumgarten, G. (ed.), Serotonergic Neurons and 5-HT Receptors in the CNS, Springer, Berlin, pp. 1-39, 49.
4. ap2) expressed in the CNS of Aplysia californica. J. Neurochem. 80:335-345.
5. Barnes, N. M., and Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
6. T2 receptor subtypes: A family re-united? Trends Pharmacol. Sci. 16:105-110.
7. 1C receptors in drug-induced penile erections in rats. Psychopharmacology 101:57-61.
8. 2C receptors. Br. J. Pharmacol. 115:622-628.
9. Cassel, J. C., and Jeltsch, H. (1995). Serotonergic modulation of cholinergic function in the central nervous system: Cognitive implications. Neuroscience 69:1-41.
10. 7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J. Pharmacol. Exp. Ther. 277:1560-1566.
11. Davies, P., and Maloney, A. F. J. (1996). Selective loss of cerebral cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
12. De Ligt, R. A. F., Kourounakis, A. P., and Ijzerman, A. P. (2000). Inverse agonism at G protein-coupled receptors: (Patho)physiological relevance and implications for drug discovery. Br. J. Pharmacol. 130:1-12.
13. Fuller, R. W. (1996). Serotonin receptors involved in the regulation of pituitary-adrenocortical function in rats. Behav. Brain. Res. 73:215-219.
14. Gower, A. J. (1992). 5-HT receptors and cognitive function. In Marsden, H. (ed.), Central Serotonin Receptors and Psychotropic Drugs, Blackwell, Oxford, pp. 239-259.
15. Greenamyre, J. T., and Young, A. B. (1989). Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging 10:593-602.
16. Harvey, J. A. (1996). Serotonergic regulation of associative learning. Behav. Brain. Res. 73:47-50.
17. T2 receptor antagonists on a cranial nerve reflex in the rabbit: Evidence for inverse agonism. Psychopharmacology 141:162-168.
18. 2C receptor. Ann. N.Y. Acad. Sci. 861:140-145.
19. T1 recognition sites. J. Recept. Res. 8:59-81.
20. 1C receptors. Trends Pharmacol. Sci. 9:89-94.
21. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., and Humphrey, P. P. A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:157-203.
22. 3H]ketanserin. Eur. J. Pharmacol. 118:13-23.
23. Hoyer, D., and Fozard, J. R. (1991). 5-Hydroxytryptamine receptors. In Doods, V. M. (ed.), Receptor Data for Biological Experiments, Ellis Horwood, New York, pp. 35-41.
24. Hoyer, D., Hannon, J. P., and Martin, G. R. (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71:533-554.
25. Hyman, B. T., Van Hoesen, G. V., and Damasio, A. R. (1987). Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone. Ann. Neurol. 22:37-40.
26. Ingram, D. K., Shimada, A., Spangler, E. L., Ikari, H., Hengemihle, J., Kuo, H., and Greig, N. (1996). Cognitive enhancement new strategies for stimulating cholinergic, glutamatergic, and nitric oxide systems. Ann. N.Y. Acad. Sci. 786:346-361.
27. Johnson, M. D. (1994). Synaptic glutamate release by postnatal rat serotonergic neurons in microculture. Neuron 12:433-442.
28. 2A antagonist with a favorable CNS safety profile. J. Pharmacol. Exp. Ther. 277:968-981.
29. 1C receptors and their therapeutic relevance. Curr. Opin. Invest. Drugs 2:317-362.
30. 1C receptors mediate 1-(3-chlorophenyl)piperazine-induced hypophagic, Br. J. Pharmacol. 103:2016-2020.
31. 2C/2B receptor antagonist. Br. J. Pharmacol. 111:797-802.
32. Krystal, J. H., Belger, A., D'Souza, D. C., Anand, A., Charney, D. S., Aghajanian, G. K., and Moghaddam, B. (1999). Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists. Neuropsychopharmacology 22:S143-S157.
33. Martin, G. R., Eglen, R. M., Hamblin, M. W., Hoyer, D., and Yocca, F. (1998). The structure and signaling properties of 5-HT receptors: An endless diversity. Trends Pharmacol. Sci. 19:2-4.
34. McGaugh, J. L. (1989). Dissociating learning and performance: Drug and hormone enhancement of memory storage. Brain Res. Bull. 23:339-345
35. Meneses, A. (1999). 5-HT system and cognition. Neurosci. Biobehav. Rev. 23:1111-1125.
36. 1B receptor inverse agonism affect learning consolidation? Neurosci. Biobehav. Rev. 25:191-201.
37. 1-7 receptors modulate memory formation in an autoshaping Pavlovian/Instrumental task. Neurosci. Biobehav. Rev. 26:309-319.
38. Meneses, A., and Hong, E. (1997a). A pharmacological analysis of serotonergic receptors: Effects of their activation or blockade in learning. Prog. Neuropsychopharmacol. Biol. Psychiatry 21:273-296.
39. 2C receptors in learning. Behav. Brain Res. 87:105-110.
40. 1A receptors modulate the consolidation of learning in normal and cognitively impaired rats. Neurobiol. Learn. Mem. 71:207-218.
41. 7) on learning. Soc. Neurosci. 24:1371.
42. 2A) in the consolidation of learning. Behav. Brain. Res. 89:217-223.
43. Packard, M. G., and Cahill. L. (2001). Affective modulation of multiple memory systems. Curr Opin. Neurobiol. 11:752-756.
44. Perry, E. K., Perry, R. H., Blessed, G., and Tomlinson, B. E. (1977). Necropsy evidence in cerebral cholinergic deficits in senile dementia. Lancet 1:189.
45. Pierce, P. A., and Peroutka, S. J. (1989). Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97:118-122.
46. 2C receptor antagonist properties of compounds. Eur. J. Pharmacol. 388:57-67.
47. Procter, A. W., Palmer, A. M., Francis, P. T., Lowe, S. L., Neary, D., Murphy, E., Doshi, R., and Bowen, D. M. (1988). Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J. Neurochem. 50:790-802.
48. 2C receptor. J. Pharmacol. Exp. Ther. 299:83-89.
49. Ruat. M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J.-M., and Schwartz, J.-C. (1993). Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl. Acad. Sci. U.S.A. 90:8547-8551.
50. Shen, Y., Monsma, F. J., Metcalf, M. A., Jose, P. A., Hamblin, M. W., and Sibley, D. R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268:18200-18204.
51. Tallman, J. E (2000). Development of novel antipsychotic drugs. Brain Res. Rev. 21:385-390.
52. T2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213-216.
53. Van Wijngaarden, I., Tulp, M. T. M., and Soudijn, W. (1990). The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. (Mol. Pharmacol. Sect.) 188:301-312.
54. 2A receptor inverse agonists as antipsychotics. J. Pharmacol. Exp. Ther. 299:268-276.
55. 2A/2C antagonists on associative learning in the rabbit. Psychopharmacology 137:157-163.
56. White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., and Bowen, D. M. (1977)., Neocortical cholinergic neurons in elderly people. Lancet 1:668-671.